TMEM212 (transmembrane protein 212) is a transmembrane protein located on chromosome 3.31 with emerging roles in neural function and metabolic regulation. Primary function involves contributions to the innate architecture of facial emotion processing: genetic variants in TMEM212 were associated with selective activation of the fusiform face area (FFA) in response to negative facial expressions, with activation patterns limited to this specialized brain region 1. The gene also appears relevant to metabolic phenotypes; SNPs near the PP13439-TMEM212 locus showed consistent association with body mass index (BMI) in African American populations, with effect sizes of 0.091-0.167 standard deviation units per effect allele 2. In cancer biology, TMEM212 emerged as one of 20 high-ranking biomarkers in transcriptome profiling studies for breast cancer prediction using machine learning approaches, achieving an area under the curve of 0.94 with logistic regression and multilayer perceptron classifiers 3. The precise molecular mechanisms underlying TMEM212's function in these diverse processes remain unclear. Clinical significance is currently limited; TMEM212 has not been identified in disease-causing mutations in pathological contexts such as polycystic kidney disease 4. Further investigation is needed to elucidate TMEM212's molecular function and confirm its utility as a biomarker or therapeutic target.